Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention
Greenhalgh J, Bagust A, Boland A, Saborido CM, Fleeman N, McLeod C, Dundar Y, Dickson R, Proudlove C, Kolamunnage-Dona R, Fisher M
Record ID 32013000627
English
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hta.ac.uk/erg/supplements/supplement1401.pdf#nameddest=article05
URL for additional information:
http://www.hta.ac.uk/1852
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Cost-Benefit Analysis
- Models, Economic
- Prasugrel Hydrochloride
- Quality of Life
- Quality-Adjusted Life Years
- Risk Assessment
- Acute Coronary Syndrome
- Angioplasty, Balloon, Coronary
- Piperazines
- Platelet Aggregation Inhibitors
- Purinergic P2Y Receptor Antagonists
- Thiophenes
- Ticlopidine
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2010 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.